nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Hyperhidrosis—Ibandronate—osteoporosis	0.0025	0.0025	CcSEcCtD
Gadoteridol—Nausea—Ergocalciferol—osteoporosis	0.0025	0.0025	CcSEcCtD
Gadoteridol—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.00249	0.00249	CcSEcCtD
Gadoteridol—Erythema—Pamidronate—osteoporosis	0.00249	0.00249	CcSEcCtD
Gadoteridol—Urticaria—Etidronic acid—osteoporosis	0.00248	0.00248	CcSEcCtD
Gadoteridol—Abdominal pain—Etidronic acid—osteoporosis	0.00247	0.00247	CcSEcCtD
Gadoteridol—Dysgeusia—Pamidronate—osteoporosis	0.00243	0.00243	CcSEcCtD
Gadoteridol—Paraesthesia—Estropipate—osteoporosis	0.00243	0.00243	CcSEcCtD
Gadoteridol—Flushing—Zoledronate—osteoporosis	0.00242	0.00242	CcSEcCtD
Gadoteridol—Malaise—Ethinyl Estradiol—osteoporosis	0.00242	0.00242	CcSEcCtD
Gadoteridol—Syncope—Risedronate—osteoporosis	0.00235	0.00235	CcSEcCtD
Gadoteridol—Cough—Ethinyl Estradiol—osteoporosis	0.00234	0.00234	CcSEcCtD
Gadoteridol—Paraesthesia—Ibandronate—osteoporosis	0.00233	0.00233	CcSEcCtD
Gadoteridol—Pain—Estropipate—osteoporosis	0.00231	0.00231	CcSEcCtD
Gadoteridol—Ill-defined disorder—Pamidronate—osteoporosis	0.00231	0.00231	CcSEcCtD
Gadoteridol—Hypersensitivity—Etidronic acid—osteoporosis	0.0023	0.0023	CcSEcCtD
Gadoteridol—Loss of consciousness—Risedronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Gadoteridol—Cough—Risedronate—osteoporosis	0.00228	0.00228	CcSEcCtD
Gadoteridol—Anxiety—Ethinyl Estradiol—osteoporosis	0.00228	0.00228	CcSEcCtD
Gadoteridol—Pain—Alendronate—osteoporosis	0.00227	0.00227	CcSEcCtD
Gadoteridol—Erythema—Zoledronate—osteoporosis	0.00227	0.00227	CcSEcCtD
Gadoteridol—Hypertension—Risedronate—osteoporosis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Discomfort—Ethinyl Estradiol—osteoporosis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Malaise—Pamidronate—osteoporosis	0.00224	0.00224	CcSEcCtD
Gadoteridol—Pain—Raloxifene—osteoporosis	0.00224	0.00224	CcSEcCtD
Gadoteridol—Syncope—Pamidronate—osteoporosis	0.00223	0.00223	CcSEcCtD
Gadoteridol—Chest pain—Risedronate—osteoporosis	0.00223	0.00223	CcSEcCtD
Gadoteridol—Dysgeusia—Zoledronate—osteoporosis	0.00222	0.00222	CcSEcCtD
Gadoteridol—Anxiety—Risedronate—osteoporosis	0.00222	0.00222	CcSEcCtD
Gadoteridol—Pain—Ibandronate—osteoporosis	0.00221	0.00221	CcSEcCtD
Gadoteridol—Pruritus—Etidronic acid—osteoporosis	0.00221	0.00221	CcSEcCtD
Gadoteridol—Feeling abnormal—Alendronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Oedema—Ethinyl Estradiol—osteoporosis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Erythema—Conjugated Estrogens—osteoporosis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Loss of consciousness—Pamidronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Dry mouth—Risedronate—osteoporosis	0.00218	0.00218	CcSEcCtD
Gadoteridol—Cough—Pamidronate—osteoporosis	0.00217	0.00217	CcSEcCtD
Gadoteridol—Pain—Calcitriol—osteoporosis	0.00217	0.00217	CcSEcCtD
Gadoteridol—Convulsion—Pamidronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Gadoteridol—Hypertension—Pamidronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Gadoteridol—Urticaria—Estropipate—osteoporosis	0.00215	0.00215	CcSEcCtD
Gadoteridol—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00214	0.00214	CcSEcCtD
Gadoteridol—Diarrhoea—Etidronic acid—osteoporosis	0.00214	0.00214	CcSEcCtD
Gadoteridol—Body temperature increased—Estropipate—osteoporosis	0.00214	0.00214	CcSEcCtD
Gadoteridol—Abdominal pain—Estropipate—osteoporosis	0.00214	0.00214	CcSEcCtD
Gadoteridol—Feeling abnormal—Ibandronate—osteoporosis	0.00213	0.00213	CcSEcCtD
Gadoteridol—Tremor—Zoledronate—osteoporosis	0.00213	0.00213	CcSEcCtD
Gadoteridol—Urticaria—Alendronate—osteoporosis	0.00211	0.00211	CcSEcCtD
Gadoteridol—Anxiety—Pamidronate—osteoporosis	0.00211	0.00211	CcSEcCtD
Gadoteridol—Ill-defined disorder—Zoledronate—osteoporosis	0.00211	0.00211	CcSEcCtD
Gadoteridol—Abdominal pain—Alendronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Gadoteridol—Body temperature increased—Alendronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Gadoteridol—Shock—Risedronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Gadoteridol—Discomfort—Pamidronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Gadoteridol—Body temperature increased—Raloxifene—osteoporosis	0.00207	0.00207	CcSEcCtD
Gadoteridol—Abdominal pain—Raloxifene—osteoporosis	0.00207	0.00207	CcSEcCtD
Gadoteridol—Urticaria—Ibandronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Gadoteridol—Malaise—Zoledronate—osteoporosis	0.00205	0.00205	CcSEcCtD
Gadoteridol—Body temperature increased—Ibandronate—osteoporosis	0.00205	0.00205	CcSEcCtD
Gadoteridol—Abdominal pain—Ibandronate—osteoporosis	0.00205	0.00205	CcSEcCtD
Gadoteridol—Syncope—Zoledronate—osteoporosis	0.00204	0.00204	CcSEcCtD
Gadoteridol—Oedema—Pamidronate—osteoporosis	0.00203	0.00203	CcSEcCtD
Gadoteridol—Anaphylactic shock—Pamidronate—osteoporosis	0.00203	0.00203	CcSEcCtD
Gadoteridol—Rhinitis—Estradiol—osteoporosis	0.00202	0.00202	CcSEcCtD
Gadoteridol—Urticaria—Calcitriol—osteoporosis	0.00201	0.00201	CcSEcCtD
Gadoteridol—Abdominal pain—Calcitriol—osteoporosis	0.002	0.002	CcSEcCtD
Gadoteridol—Body temperature increased—Calcitriol—osteoporosis	0.002	0.002	CcSEcCtD
Gadoteridol—Shock—Pamidronate—osteoporosis	0.002	0.002	CcSEcCtD
Gadoteridol—Loss of consciousness—Zoledronate—osteoporosis	0.002	0.002	CcSEcCtD
Gadoteridol—Hypersensitivity—Estropipate—osteoporosis	0.00199	0.00199	CcSEcCtD
Gadoteridol—Vomiting—Etidronic acid—osteoporosis	0.00198	0.00198	CcSEcCtD
Gadoteridol—Cough—Zoledronate—osteoporosis	0.00198	0.00198	CcSEcCtD
Gadoteridol—Rash—Etidronic acid—osteoporosis	0.00197	0.00197	CcSEcCtD
Gadoteridol—Convulsion—Zoledronate—osteoporosis	0.00197	0.00197	CcSEcCtD
Gadoteridol—Dermatitis—Etidronic acid—osteoporosis	0.00197	0.00197	CcSEcCtD
Gadoteridol—Hyperhidrosis—Pamidronate—osteoporosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Syncope—Conjugated Estrogens—osteoporosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Hypertension—Zoledronate—osteoporosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Hypersensitivity—Alendronate—osteoporosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Headache—Etidronic acid—osteoporosis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Chest pain—Zoledronate—osteoporosis	0.00193	0.00193	CcSEcCtD
Gadoteridol—Anxiety—Zoledronate—osteoporosis	0.00193	0.00193	CcSEcCtD
Gadoteridol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00192	0.00192	CcSEcCtD
Gadoteridol—Paraesthesia—Risedronate—osteoporosis	0.00192	0.00192	CcSEcCtD
Gadoteridol—Pruritus—Estropipate—osteoporosis	0.00191	0.00191	CcSEcCtD
Gadoteridol—Discomfort—Zoledronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Gadoteridol—Hypersensitivity—Ibandronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Gadoteridol—Cough—Conjugated Estrogens—osteoporosis	0.00191	0.00191	CcSEcCtD
Gadoteridol—Dyspnoea—Risedronate—osteoporosis	0.0019	0.0019	CcSEcCtD
Gadoteridol—Hypotension—Pamidronate—osteoporosis	0.0019	0.0019	CcSEcCtD
Gadoteridol—Convulsion—Conjugated Estrogens—osteoporosis	0.00189	0.00189	CcSEcCtD
Gadoteridol—Dry mouth—Zoledronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Gadoteridol—Pruritus—Alendronate—osteoporosis	0.00188	0.00188	CcSEcCtD
Gadoteridol—Tinnitus—Estradiol—osteoporosis	0.00187	0.00187	CcSEcCtD
Gadoteridol—Hypersensitivity—Calcitriol—osteoporosis	0.00187	0.00187	CcSEcCtD
Gadoteridol—Flushing—Estradiol—osteoporosis	0.00187	0.00187	CcSEcCtD
Gadoteridol—Chest pain—Conjugated Estrogens—osteoporosis	0.00186	0.00186	CcSEcCtD
Gadoteridol—Anxiety—Conjugated Estrogens—osteoporosis	0.00186	0.00186	CcSEcCtD
Gadoteridol—Nausea—Etidronic acid—osteoporosis	0.00185	0.00185	CcSEcCtD
Gadoteridol—Anaphylactic shock—Zoledronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Gadoteridol—Oedema—Zoledronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Gadoteridol—Diarrhoea—Estropipate—osteoporosis	0.00185	0.00185	CcSEcCtD
Gadoteridol—Pruritus—Ibandronate—osteoporosis	0.00183	0.00183	CcSEcCtD
Gadoteridol—Pain—Risedronate—osteoporosis	0.00183	0.00183	CcSEcCtD
Gadoteridol—Shock—Zoledronate—osteoporosis	0.00182	0.00182	CcSEcCtD
Gadoteridol—Paraesthesia—Pamidronate—osteoporosis	0.00182	0.00182	CcSEcCtD
Gadoteridol—Diarrhoea—Alendronate—osteoporosis	0.00182	0.00182	CcSEcCtD
Gadoteridol—Dyspnoea—Pamidronate—osteoporosis	0.00181	0.00181	CcSEcCtD
Gadoteridol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.0018	0.0018	CcSEcCtD
Gadoteridol—Pruritus—Calcitriol—osteoporosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Hyperhidrosis—Zoledronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Diarrhoea—Raloxifene—osteoporosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Dizziness—Estropipate—osteoporosis	0.00179	0.00179	CcSEcCtD
Gadoteridol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00178	0.00178	CcSEcCtD
Gadoteridol—Oedema—Conjugated Estrogens—osteoporosis	0.00178	0.00178	CcSEcCtD
Gadoteridol—Diarrhoea—Ibandronate—osteoporosis	0.00177	0.00177	CcSEcCtD
Gadoteridol—Dizziness—Alendronate—osteoporosis	0.00176	0.00176	CcSEcCtD
Gadoteridol—Shock—Conjugated Estrogens—osteoporosis	0.00176	0.00176	CcSEcCtD
Gadoteridol—Erythema—Estradiol—osteoporosis	0.00175	0.00175	CcSEcCtD
Gadoteridol—Urticaria—Ethinyl Estradiol—osteoporosis	0.00174	0.00174	CcSEcCtD
Gadoteridol—Pain—Pamidronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Gadoteridol—Diarrhoea—Calcitriol—osteoporosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Hypotension—Zoledronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Dizziness—Raloxifene—osteoporosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Vomiting—Estropipate—osteoporosis	0.00172	0.00172	CcSEcCtD
Gadoteridol—Dysgeusia—Estradiol—osteoporosis	0.00171	0.00171	CcSEcCtD
Gadoteridol—Dizziness—Ibandronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Gadoteridol—Rash—Estropipate—osteoporosis	0.0017	0.0017	CcSEcCtD
Gadoteridol—Dermatitis—Estropipate—osteoporosis	0.0017	0.0017	CcSEcCtD
Gadoteridol—Urticaria—Risedronate—osteoporosis	0.0017	0.0017	CcSEcCtD
Gadoteridol—Headache—Estropipate—osteoporosis	0.00169	0.00169	CcSEcCtD
Gadoteridol—Vomiting—Alendronate—osteoporosis	0.00169	0.00169	CcSEcCtD
Gadoteridol—Body temperature increased—Risedronate—osteoporosis	0.00169	0.00169	CcSEcCtD
Gadoteridol—Abdominal pain—Risedronate—osteoporosis	0.00169	0.00169	CcSEcCtD
Gadoteridol—Rash—Alendronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Gadoteridol—Dermatitis—Alendronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Gadoteridol—Feeling abnormal—Pamidronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Gadoteridol—Hypotension—Conjugated Estrogens—osteoporosis	0.00167	0.00167	CcSEcCtD
Gadoteridol—Headache—Alendronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Gadoteridol—Paraesthesia—Zoledronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Gadoteridol—Vomiting—Raloxifene—osteoporosis	0.00166	0.00166	CcSEcCtD
Gadoteridol—Dyspnoea—Zoledronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Gadoteridol—Rash—Raloxifene—osteoporosis	0.00165	0.00165	CcSEcCtD
Gadoteridol—Dermatitis—Raloxifene—osteoporosis	0.00165	0.00165	CcSEcCtD
Gadoteridol—Vomiting—Ibandronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Gadoteridol—Tremor—Estradiol—osteoporosis	0.00164	0.00164	CcSEcCtD
Gadoteridol—Headache—Raloxifene—osteoporosis	0.00164	0.00164	CcSEcCtD
Gadoteridol—Rash—Ibandronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Gadoteridol—Dermatitis—Ibandronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Gadoteridol—Ill-defined disorder—Estradiol—osteoporosis	0.00162	0.00162	CcSEcCtD
Gadoteridol—Headache—Ibandronate—osteoporosis	0.00162	0.00162	CcSEcCtD
Gadoteridol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00161	0.00161	CcSEcCtD
Gadoteridol—Vomiting—Calcitriol—osteoporosis	0.00161	0.00161	CcSEcCtD
Gadoteridol—Nausea—Estropipate—osteoporosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Abdominal pain—Pamidronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Body temperature increased—Pamidronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Rash—Calcitriol—osteoporosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Dermatitis—Calcitriol—osteoporosis	0.0016	0.0016	CcSEcCtD
Gadoteridol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00159	0.00159	CcSEcCtD
Gadoteridol—Headache—Calcitriol—osteoporosis	0.00159	0.00159	CcSEcCtD
Gadoteridol—Pain—Zoledronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Nausea—Alendronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Malaise—Estradiol—osteoporosis	0.00158	0.00158	CcSEcCtD
Gadoteridol—Hypersensitivity—Risedronate—osteoporosis	0.00157	0.00157	CcSEcCtD
Gadoteridol—Syncope—Estradiol—osteoporosis	0.00157	0.00157	CcSEcCtD
Gadoteridol—Nausea—Raloxifene—osteoporosis	0.00155	0.00155	CcSEcCtD
Gadoteridol—Pruritus—Ethinyl Estradiol—osteoporosis	0.00155	0.00155	CcSEcCtD
Gadoteridol—Nausea—Ibandronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Gadoteridol—Loss of consciousness—Estradiol—osteoporosis	0.00154	0.00154	CcSEcCtD
Gadoteridol—Feeling abnormal—Zoledronate—osteoporosis	0.00153	0.00153	CcSEcCtD
Gadoteridol—Cough—Estradiol—osteoporosis	0.00153	0.00153	CcSEcCtD
Gadoteridol—Pain—Conjugated Estrogens—osteoporosis	0.00153	0.00153	CcSEcCtD
Gadoteridol—Hypertension—Estradiol—osteoporosis	0.00151	0.00151	CcSEcCtD
Gadoteridol—Pruritus—Risedronate—osteoporosis	0.00151	0.00151	CcSEcCtD
Gadoteridol—Nausea—Calcitriol—osteoporosis	0.00151	0.00151	CcSEcCtD
Gadoteridol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.0015	0.0015	CcSEcCtD
Gadoteridol—Hypersensitivity—Pamidronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Gadoteridol—Chest pain—Estradiol—osteoporosis	0.00149	0.00149	CcSEcCtD
Gadoteridol—Anxiety—Estradiol—osteoporosis	0.00148	0.00148	CcSEcCtD
Gadoteridol—Urticaria—Zoledronate—osteoporosis	0.00147	0.00147	CcSEcCtD
Gadoteridol—Discomfort—Estradiol—osteoporosis	0.00147	0.00147	CcSEcCtD
Gadoteridol—Body temperature increased—Zoledronate—osteoporosis	0.00147	0.00147	CcSEcCtD
Gadoteridol—Abdominal pain—Zoledronate—osteoporosis	0.00147	0.00147	CcSEcCtD
Gadoteridol—Diarrhoea—Risedronate—osteoporosis	0.00146	0.00146	CcSEcCtD
Gadoteridol—Dry mouth—Estradiol—osteoporosis	0.00146	0.00146	CcSEcCtD
Gadoteridol—Dizziness—Ethinyl Estradiol—osteoporosis	0.00145	0.00145	CcSEcCtD
Gadoteridol—Pruritus—Pamidronate—osteoporosis	0.00144	0.00144	CcSEcCtD
Gadoteridol—Anaphylactic shock—Estradiol—osteoporosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Oedema—Estradiol—osteoporosis	0.00143	0.00143	CcSEcCtD
Gadoteridol—Urticaria—Conjugated Estrogens—osteoporosis	0.00142	0.00142	CcSEcCtD
Gadoteridol—Dizziness—Risedronate—osteoporosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Shock—Estradiol—osteoporosis	0.00141	0.00141	CcSEcCtD
Gadoteridol—Vomiting—Ethinyl Estradiol—osteoporosis	0.00139	0.00139	CcSEcCtD
Gadoteridol—Diarrhoea—Pamidronate—osteoporosis	0.00139	0.00139	CcSEcCtD
Gadoteridol—Hyperhidrosis—Estradiol—osteoporosis	0.00138	0.00138	CcSEcCtD
Gadoteridol—Rash—Ethinyl Estradiol—osteoporosis	0.00138	0.00138	CcSEcCtD
Gadoteridol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00138	0.00138	CcSEcCtD
Gadoteridol—Headache—Ethinyl Estradiol—osteoporosis	0.00137	0.00137	CcSEcCtD
Gadoteridol—Hypersensitivity—Zoledronate—osteoporosis	0.00137	0.00137	CcSEcCtD
Gadoteridol—Vomiting—Risedronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Gadoteridol—Rash—Risedronate—osteoporosis	0.00135	0.00135	CcSEcCtD
Gadoteridol—Dermatitis—Risedronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Gadoteridol—Dizziness—Pamidronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Gadoteridol—Headache—Risedronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Gadoteridol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00131	0.00131	CcSEcCtD
Gadoteridol—Pruritus—Zoledronate—osteoporosis	0.00131	0.00131	CcSEcCtD
Gadoteridol—Nausea—Ethinyl Estradiol—osteoporosis	0.0013	0.0013	CcSEcCtD
Gadoteridol—Vomiting—Pamidronate—osteoporosis	0.00129	0.00129	CcSEcCtD
Gadoteridol—Paraesthesia—Estradiol—osteoporosis	0.00128	0.00128	CcSEcCtD
Gadoteridol—Rash—Pamidronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Gadoteridol—Dermatitis—Pamidronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Gadoteridol—Dyspnoea—Estradiol—osteoporosis	0.00127	0.00127	CcSEcCtD
Gadoteridol—Headache—Pamidronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Gadoteridol—Diarrhoea—Zoledronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Gadoteridol—Nausea—Risedronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Gadoteridol—Pruritus—Conjugated Estrogens—osteoporosis	0.00126	0.00126	CcSEcCtD
Gadoteridol—Dizziness—Zoledronate—osteoporosis	0.00123	0.00123	CcSEcCtD
Gadoteridol—Pain—Estradiol—osteoporosis	0.00122	0.00122	CcSEcCtD
Gadoteridol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00122	0.00122	CcSEcCtD
Gadoteridol—Nausea—Pamidronate—osteoporosis	0.00121	0.00121	CcSEcCtD
Gadoteridol—Dizziness—Conjugated Estrogens—osteoporosis	0.00118	0.00118	CcSEcCtD
Gadoteridol—Vomiting—Zoledronate—osteoporosis	0.00118	0.00118	CcSEcCtD
Gadoteridol—Feeling abnormal—Estradiol—osteoporosis	0.00118	0.00118	CcSEcCtD
Gadoteridol—Rash—Zoledronate—osteoporosis	0.00117	0.00117	CcSEcCtD
Gadoteridol—Dermatitis—Zoledronate—osteoporosis	0.00117	0.00117	CcSEcCtD
Gadoteridol—Headache—Zoledronate—osteoporosis	0.00116	0.00116	CcSEcCtD
Gadoteridol—Vomiting—Conjugated Estrogens—osteoporosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Urticaria—Estradiol—osteoporosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Abdominal pain—Estradiol—osteoporosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Body temperature increased—Estradiol—osteoporosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Rash—Conjugated Estrogens—osteoporosis	0.00113	0.00113	CcSEcCtD
Gadoteridol—Dermatitis—Conjugated Estrogens—osteoporosis	0.00112	0.00112	CcSEcCtD
Gadoteridol—Headache—Conjugated Estrogens—osteoporosis	0.00112	0.00112	CcSEcCtD
Gadoteridol—Nausea—Zoledronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Gadoteridol—Nausea—Conjugated Estrogens—osteoporosis	0.00106	0.00106	CcSEcCtD
Gadoteridol—Hypersensitivity—Estradiol—osteoporosis	0.00105	0.00105	CcSEcCtD
Gadoteridol—Pruritus—Estradiol—osteoporosis	0.00101	0.00101	CcSEcCtD
Gadoteridol—Diarrhoea—Estradiol—osteoporosis	0.000977	0.000977	CcSEcCtD
Gadoteridol—Dizziness—Estradiol—osteoporosis	0.000944	0.000944	CcSEcCtD
Gadoteridol—Vomiting—Estradiol—osteoporosis	0.000908	0.000908	CcSEcCtD
Gadoteridol—Rash—Estradiol—osteoporosis	0.000901	0.000901	CcSEcCtD
Gadoteridol—Dermatitis—Estradiol—osteoporosis	0.0009	0.0009	CcSEcCtD
Gadoteridol—Headache—Estradiol—osteoporosis	0.000895	0.000895	CcSEcCtD
Gadoteridol—Nausea—Estradiol—osteoporosis	0.000848	0.000848	CcSEcCtD
